NAFLD is divided into two types: simple fatty liver and nonalcoholic steatohepatitis (NASH). Most people with NAFLD have simple fatty liver, however 25-30% have NASH. With NASH, there is inflammation and scarring of the liver. A small number of people will develop significant scarring in their liver, called cirrhosis.
We at Headlands Research conduct clinical trials for investigative medications for the treatment of NAFLD.
Sign up with the form below to learn more information about our clinical trial opportunities!
If you are interested in participating in this study, please complete the following preliminary qualification form.
We will follow-up with you after we have received your submission.